Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation

yana Beulque; Anne-Leen Deleu; Kevin Punie; Liesbeth de Wever; Marcella Baldewijns; Stefano Caruso; Gabrielle Couchy; Jessica Zucman-Rossi; Benoit Beuselinck

doi:10.1016/j.clgc.2019.06.013

Journal articles

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation

yana Beulque ¹ Anne-Leen Deleu ¹ Kevin Punie ¹ Liesbeth de Wever ¹ Marcella Baldewijns ¹ Stefano Caruso ² Gabrielle Couchy ² Jessica Zucman-Rossi ² Benoit Beuselinck ¹

1 KU Leuven - Catholic University of Leuven - Katholieke Universiteit Leuven

2 U1162 - Génomique Fonctionnelle des Tumeurs Solides

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Hépatology and Gastroenterology

Complete list of metadata

https://www.hal.inserm.fr/inserm-02532762
Contributor : Jessica Zucman-Rossi Connect in order to contact the contributor
Submitted on : Monday, April 6, 2020 - 9:00:16 AM
Last modification on : Wednesday, April 8, 2020 - 1:47:18 AM

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation

Identifiers

Collections

Citation

Export

Metrics

13

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation

Identifiers

Collections

Citation

Export

Share

Metrics

13